The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| HTFL | N/A | N/A | N/A | -3% |
| S&P | +13.22% | +85.17% | +13.11% | +7% |
HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.
A billionaire family office has made a big bet on a newly public AI-driven heart diagnostics company—here’s what long-term investors should take from the move.
Bain Capital added more than 12.4 million shares of HeartFlow stock in the thrid quarter
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $46.28M | 0.0% |
| Gross Profit | $35.42M | 0.0% |
| Gross Margin | 76.53% | 0.0% |
| Market Cap | $2.81B | 0.0% |
| Market Cap / Employee | $4.02M | 0.0% |
| Employees | 699 | 0.0% |
| Net Income | -$50.86M | 0.0% |
| EBITDA | -$13.01M | 0.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $291.17M | 0.0% |
| Accounts Receivable | $27.86M | 0.0% |
| Inventory | 0 | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $16.27M | 0.0% |
| Short Term Debt | $5.52M | 0.0% |
| Current | YOY Change | |
|---|---|---|
| Return On Invested Capital | -107.93% | 0.0% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$4.19M | 0.0% |
| Operating Free Cash Flow | -$2.96M | 0.0% |
| Metric | Q3 2025 | YoY Change | ||
|---|---|---|---|---|
| Price to Book | -3.14 | - | ||
| Price to Tangible Book Value | -3.14 | - | ||
| Enterprise Value to EBITDA | -195.25 | - | ||
| Total Debt | $203.28M | $205.15M | $21.79M | - |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
